Skip Navigation LinksPublicly-available-resources

These resources have been made available to the general public as part of ECRI Institute’s mission to help others find new approaches to improve patient safety.

 Ranked by the most recent items

 

 

Implementing the ENFit Initiative for Preventing Enteral Tubing Misconnectionshttps://www.ecri.org/components/HDJournal/Pages/ENFit-for-Preventing-Enteral-Tubing-Misconnections.aspxImplementing the ENFit Initiative for Preventing Enteral Tubing Misconnections3/29/2017 12:00:00 AMLearn about the ENFit enteral connector initiative for preventing enteral tubing misconnections. We explain why it's important and what actions you should take to transition to the new enteral connectors.
Partnering for Transformation: Making a Positive Impact https://www.ecri.org/components/HRC/Pages/Proceedings2017.aspxPartnering for Transformation: Making a Positive Impact 2/27/2017 12:00:00 AM​In its third annual meeting, The Partnership for Health IT and Patient Safety updated attendees on implementing and testing the recommendations included in the copy and paste toolkit, as well as the Partnership's new safe practice recommendations for the use of health IT in patient identification.
Lithoplasty System (Shockwave Medical, Inc.) for Treating Peripheral Artery Diseasehttps://www.ecri.org/components/ProductBriefs/Pages/24665.aspxLithoplasty System (Shockwave Medical, Inc.) for Treating Peripheral Artery Disease1/13/2017 12:00:00 AM​The Lithoplasty System combines sound waves with angioplasty to treat calcified plaque in diseased peripheral arteries. The system consists of three components a single-use proprietary balloon catheter, a reusable generator, and a reusable connector cable. The balloon catheter has integrated lithotripsy emitters designed to enhance angioplasty by disrupting calcium before balloon dilation of the stenosis.
Rapid Point-of-care Blood Testing in the Home Healthcare Settinghttps://www.ecri.org/components/Hotline/Pages/24876.aspxRapid Point-of-care Blood Testing in the Home Healthcare Setting1/11/2017 12:00:00 AM​Point-of-care testing (POCT) is done near a patient, often at the bedside, and can be conducted in-hospital or outside the hospital. POCT is usually performed by nurses, physicians, paramedics, or patients who are not trained in laboratory testing procedures. POCT's main advantage is the rapid turnaround time for results and that it typically requires less sample volume. This Hotline Response looks specifically at POCT use in the home healthcare setting and at the commercial kits and devices designed for use in this setting.
Acute Oxygen Therapyhttps://www.ecri.org/components/SpecialReports/Pages/24629.aspxAcute Oxygen Therapy10/14/2016 12:00:00 AM​Acute oxygen therapy is one of the most commonly used medical procedures, but many clinicians and healthcare workers responsible for its use may not be aware of the potential risks to patients if not used correctly. This Special Report looks at the current literature on when and how to use oxygen supplementation in critically ill patients to treat hypoxemia while avoiding hyperoxemia.
A Hospital Survival Story: Avoiding Medicare Terminationhttps://www.ecri.org/components/HRC/Pages/RMRep0816.aspxA Hospital Survival Story: Avoiding Medicare Termination8/26/2016 12:00:00 AMThe board chair of a California community hospital that recently faced near-termination from the Medicare program has a message for all healthcare organizations.
Managing Patient Complaints and Grievanceshttps://www.ecri.org/components/HRC/Pages/PtSup1.aspxManaging Patient Complaints and Grievances8/17/2016 12:00:00 AMProactive management of patient complaints and grievances is important to ensure regulatory compliance and excellent customer service, as well as for using lessons learned to remediate systems problems and staff performance issues.
Partnering for Action: Applying What We’ve Learnedhttps://www.ecri.org/components/HRC/Pages/Proceedings2016.aspxPartnering for Action: Applying What We’ve Learned4/7/2016 12:00:00 AMOn October 16, 2015, ECRI Institute convened a face-to-face, multi-stakeholder meeting of the Partnership for Health IT Patient Safety. "Partnering for Action Applying What We've Learned" was designed to address risks associated with health information technology (IT), to define safe practices, and to strategize on how to inform a national strategy for health IT safety.
Fallshttps://www.ecri.org/components/HRC/Pages/SafSec2.aspxFalls3/14/2016 12:00:00 AMFalls are a high-volume, high-risk, high-cost challenge for healthcare facilities worldwide. This guidance article provides risk managers with guidance on implementing a comprehensive falls management program.
Sepsis: Combating the Hidden Colossushttps://www.ecri.org/components/HRC/Pages/RMRep1215_Focus.aspxSepsis: Combating the Hidden Colossus12/1/2015 12:00:00 AMSepsis, a leading cause of death, requires prompt recognition, diagnosis, and treatment. This article examines what some organizations are doing to combat this underrecognized condition.​
Technologies for Decontaminating Medical Equipment Used for Patients with Ebola Virus Diseasehttps://www.ecri.org/components/Hotline/Pages/23413.aspxTechnologies for Decontaminating Medical Equipment Used for Patients with Ebola Virus Disease6/3/2015 12:00:00 AM​The CDC recommends using “dedicated medical equipment (preferably disposable, when possible)” in caring for patients with EVD. In cases in which nondedicated and/or nondisposable medical equipment (e.g., patient monitors, stethoscopes, infusion pumps, ventilators, dialysis equipment) are used for patient care, the CDC recommends cleaning and disinfecting them according to manufacturer's instructions and hospital policies.
ReEBOV Antigen Rapid Test (Corgenix Medical Corp.) for Diagnosing Ebola Virus Diseasehttps://www.ecri.org/components/ProductBriefs/Pages/23488.aspxReEBOV Antigen Rapid Test (Corgenix Medical Corp.) for Diagnosing Ebola Virus Disease3/13/2015 12:00:00 AM​The ReEBOV™ Antigen Rapid Test is a point-of-care assay intended to quickly diagnose Ebola virus disease in patients with signs and symptoms who may have been exposed to the virus. FDA granted Emergency Use Authorization for the test in February 2015 to detect the Zaire strain.
Ebola Vaccine Candidate cAd3-EBO (GlaxoSmithKline) for Preventing Ebola Virus Diseasehttps://www.ecri.org/components/ProductBriefs/Pages/14467.aspxEbola Vaccine Candidate cAd3-EBO (GlaxoSmithKline) for Preventing Ebola Virus Disease3/3/2015 12:00:00 AM​The search continues for a treatment and vaccine with potential to control the Ebola virus. This Product Brief explores the available evidence on the Ebola vaccine candidate cAd3-EBO, developed by GlaxoSmithKline and the National Institutes of Health.
Partnering for Success: A Call to Actionhttps://www.ecri.org/components/HRC/Pages/RMRep0215_Focus.aspxPartnering for Success: A Call to Action2/1/2015 12:00:00 AM​In 2013, ECRI Institute convened the Partnership for Health IT Patient Safety, a multi-stakeholder collaborative whose purpose is to make health IT safer together. These Proceedings cover the health IT topics, challenges, barriers, and priorities that emerged at the Partnership's September 23, 2014 meeting, Partnering for Success. The meeting underscored that health IT safety and innovation are shared responsibilities and focused on ways to advance safety through collaboration.
LightMix Ebola Zaire rRT-PCR Test (TIB Molbiol GmbH/Roche) for Diagnosing Ebola Virus Diseasehttps://www.ecri.org/components/ProductBriefs/Pages/14455.aspxLightMix Ebola Zaire rRT-PCR Test (TIB Molbiol GmbH/Roche) for Diagnosing Ebola Virus Disease1/23/2015 12:00:00 AM​This report looks at the literature for the LightMix® Ebola Zaire rRT-PCR test (TIB Molbiol/Roche), which has received Emergency Use Authorization from FDA for diagnosing Ebola virus disease.
Scope of Practice Laws for Nurse Practitioners and Physician Assistantshttps://www.ecri.org/components/PPRM/Pages/LB5.aspxScope of Practice Laws for Nurse Practitioners and Physician Assistants1/5/2015 12:00:00 AM​Nonphysician practitioners’ scope of practice is largely dictated by state laws and regulations and is also impacted by other factors such as employment agreements, practice setting, and billing requirements of Medicare and other payers.
Automated Technologies for Patient Room Disinfection and Decontamination of Biosafety Level 4 Infectious Agents, Including Ebola Virushttps://www.ecri.org/components/Hotline/Pages/14374.aspxAutomated Technologies for Patient Room Disinfection and Decontamination of Biosafety Level 4 Infectious Agents, Including Ebola Virus12/22/2014 12:00:00 AM​We explore the literature on automated means of disinfecting patient rooms and the decontamination of Biosafety Level 4 infectious agents, including Ebola virus.
Rapid Point-of-care Tests for Diagnosing Ebola Virus Diseasehttps://www.ecri.org/components/Hotline/Pages/14373.aspxRapid Point-of-care Tests for Diagnosing Ebola Virus Disease11/24/2014 12:00:00 AM​In our efforts to monitor developments in Ebola treatment, we examine the literature on rapid point-of-care testing, which is intended for use in various settings proximal to a patient, such as at the bedside, in the home, or in the ER, which may of particular utility in developing nations.
Zmapp Monoclonal Antibody Cocktail (Mapp Biopharmaceutical/LeafBio, Inc.) for Treating Ebola Virus Diseasehttps://www.ecri.org/components/ProductBriefs/Pages/14370.aspxZmapp Monoclonal Antibody Cocktail (Mapp Biopharmaceutical/LeafBio, Inc.) for Treating Ebola Virus Disease11/20/2014 12:00:00 AM​We examine the literature on the ZMappTM, which is a drug under development that comprises three monoclonal antibodies to treat patients with Ebola virus disease. The drug combines a previously existing antibody cocktail and two from a different antibody cocktail called ZMab.
AVI 6002 (AVI-7537) Drug Therapy (Sarepta Therapeutics) for Treating Ebola Virus Diseasehttps://www.ecri.org/components/ProductBriefs/Pages/14371.aspxAVI 6002 (AVI-7537) Drug Therapy (Sarepta Therapeutics) for Treating Ebola Virus Disease11/18/2014 12:00:00 AM​We examine the published clinical evidence on how well AVI-6002 (Sarepta Therapeutics) Ebola virus disease affected patients.
Patient Safety, Risk, and Qualityhttps://www.ecri.org/components/HRC/Pages/RiskQual4.aspxPatient Safety, Risk, and Quality11/18/2014 12:00:00 AMThis Risk Analysis examines the roles that quality risk assurance and risk management play in healthcare organizations, and discusses organizational models for integrating the two programs.
Aethlon Hemopurifier (Aethlon Medical) for Purifying Blood Infected with Ebola or Other Hemorrhagic Viruseshttps://www.ecri.org/components/ProductBriefs/Pages/14369.aspxAethlon Hemopurifier (Aethlon Medical) for Purifying Blood Infected with Ebola or Other Hemorrhagic Viruses11/17/2014 12:00:00 AM​We explore the literature on the Aethlon Hemopurifier™ (Aethlon Medical, Inc.), which is intended to purify blood infected with Ebola or other hemorrhagic viruses.
Medical Devices’ Role in Causing Pressure Ulcershttps://www.ecri.org/components/PSOCore/Pages/PSONav0814.aspxMedical Devices’ Role in Causing Pressure Ulcers8/1/2014 12:00:00 AM​This issue of the national PSO Navigator reviews events of pressure ulcers caused by medical devices to identify common findings.
Patient Safety E-lerts: When Patients Leave against Medical Advicehttps://www.ecri.org/components/PSOCore/Pages/E-lert_071814.aspxPatient Safety E-lerts: When Patients Leave against Medical Advice7/18/2014 12:00:00 AM​Patient Safety E-lerts July 18, 2014
Ask HRC: Texting Physician Orders? OMG!https://www.ecri.org/components/HRC/Pages/AskHRC052714.aspxAsk HRC: Texting Physician Orders? OMG!5/27/2014 12:00:00 AM​ECRI Institute members have asked about risks associated with texting of physician orders.
Fecal Microbiota Transplantation for Treating Recurrent Clostridium difficile Infectionhttps://www.ecri.org/components/Target/Pages/12037.aspxFecal Microbiota Transplantation for Treating Recurrent Clostridium difficile Infection7/21/2016 12:00:00 AMFecal microbiota transplantation involves introducing saline-diluted fecal matter from a healthy donor into the gastrointestinal tract of a patient with recurrent Clostridium difficile infection.
Wearable Artificial Kidney for Kidney Dialysishttps://www.ecri.org/components/Forecast/Pages/11373.aspxWearable Artificial Kidney for Kidney Dialysis4/18/2017 12:00:00 AMWearable artificial kidneys (WAKs) are intended to let patients undergo continuous dialysis that more closely simulates normal kidney function, potentially improving outcomes and quality of life. As of April 2017, only one WAK had begun U.S. clinical trials.